A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

March 24, 2018

Study Completion Date

March 24, 2018

Conditions

TQT Study

Interventions

DRUG

Tetrodotoxin

A single TTX dose in a dose ascending study

DRUG

Placebos

matching placebo comparator

Trial Locations (1)

Celerion, Tempe